Viewing Study NCT03977467


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-01-01 @ 12:13 PM
Study NCT ID: NCT03977467
Status: COMPLETED
Last Update Posted: 2025-08-27
First Post: 2019-05-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor
Sponsor: SCRI Development Innovations, LLC
Organization: